April 7, 2015, from 4-8:30 pm at OHSU in the Joseph Vey Conference Center
- 11th Floor, Doernbecher Children’s Hospital
- 700 SW Campus Drive
- Portland, OR 97239
General Info
Registration
Schedule
Time
|
Presenter
|
Title
|
3:30 pm
|
Registration
|
|
4:00-5:00
|
Sekar Kathiresan, M.D.
|
Leveraging human knockouts to understand risk for and protection from disease
|
5:00 to 6:10
|
|
Poster session and reception
|
6:10 to 6:20
|
Mary Stenzel-Poore, Ph.D., Senior Associate Dean for Research, School of Medicine
|
Introduction
|
6:20 to 6:30
|
Laura Hays, Ph.D., Executive Director, Fanconi Anemia Research Fund
|
Making a difference: the David Frohnmayer advocacy formula
|
6:30 to 6:35
|
Maureen Hoatlin
|
OHSU Rare Disease Consortium overview and objective of the symposium
|
6:35 to 6:45
|
Eric Orwoll, M.D.
|
Osteogenesis imperfecta: a brittle bone disease with well-definedmolecular pathologies but limited clinical insights and therapies
|
6:45 to 6:55
|
David Sprio, M.D.
|
A novel Real patient video platform that enables patients and clinicians to share rare disease phenotypes
|
6:55 to 7:05
|
Evan Shereck, M.D.
|
Overview of the program in Pediatric Immunodeficiency Rare Disease Research Clinical Network
|
7:05 to 7:10
|
Markus Grompe, M.D.
|
Program in Fanconi anemia
|
7:10 to 7:20
|
Cary Harding, M.D.
|
Clinical Trials in inborn errrors of amino acid and fatty acid metabolism
|
7:20 to 7:40
|
David Ellison, M.D.
|
- Part 1: All about that Bass: rare gene mutations and human blood pressure variation.
- Part 2: How OCTRI can help rare disease research at OHSU
|
7:40 to 8:20
|
Xiaobing Quan, M.D., Ph.D
|
Accelerating opportunities from discovery to clinic in rare disease research
|
8:20 to 8:25
|
Maureen Hoatlin
|
Final Remarks, Action items, organizing for the future
|
8:25 to 8:30
|
|
iPad Giveaway
|
|